Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: Correction: Extracellular matrix remodeling proteins as biomarkers for clinical assessment and treatment outcomes in eosinophilic esophagitis

Fig. 3

Neutrophil activity elevated with increased disease activity. Baseline biomarker levels of CPa9-HNE are plotted for patients with an EREFS inflammatory subscore of 0–1 (‘mild inflammatory endotype’; n = 11) and 2–3 (‘severe inflammatory endotype’; n = 17) after-intervention (A). The statistical difference was calculated by Mann–Whitney, with significance as p < 0.05 *

Back to article page